Nivalon Medical has produced a fully patient-specific, motion-preserving, metal-free spinal implant using ceramic 3D printing. The implant thus sets new standards for additive manufacturing in the medical sector.
EvoFlex implant from Nivalon Medical consists of a bone-like ZTA ceramic that is precisely adapted to the anatomy of each patient.
(Image: Nivalon)
Conventional spinal implants are manufactured in standard sizes and therefore cannot be optimally adapted to the individual anatomy of each patient. This leads to suboptimal load distribution, implant displacement and long-term complications. Metal incompatibilities and adverse biological reactions pose additional risks.What began as a personal mission of Todd Hodrinsky and Marcel Janse, co-founders of Nivalon Medical Technologies, has evolved into a new approach to spinal care, replacing metal with bone-like ceramics, standard sizes with a patient-specific design and rigid fixation with natural biomechanics. "We realized that the problem was not with the surgeons, but with the implants," says Hodrinsky. "We had tried to treat a living biological structure with industrial metal elements that do not behave like bone and are unable to follow the natural movements of the spine. It was clear that we had to develop something fundamentally new and better."
Gallery
Together with the Youngstown Business Incubator (YBI), Nivalon has developed the groundbreaking EvoFlex medical device. It combines a proprietary architecture of zirconia-reinforced alumina ceramic (ZTA), which has bone-like properties, with a flexible elastomeric core to mimic the natural movement of the spine. The result is a new category of spinal implants that take into account both human anatomy and natural biomechanics. The first application in patients is planned for 2026, including Todd Hodrinsky, co-founder and CEO of Nivalon. Unlike conventional implants, which are manufactured in standard sizes from metal alloys, Nivalon's EvoFlex is digitally designed based on each patient's CT data and precisely customized to their individual anatomy using 3D printing. The result is a bone-like ceramic structure that eliminates metal-related complications such as corrosion, ion release, stiffness differences and imaging interference without compromising the natural movements of the spine.
Better Material Properties And Higher Biocompatibility After Sintering
Using XJet's NanoParticle Jetting ceramic 3D printing technology, Nivalon was able to design and manufacture a load-bearing spinal implant architecture made of pure, high-density ceramic. "For us, XJet is not only the best platform for manufacturing implants from high-performance ceramics—it's also a key enabler for our personalized approach," says Hodrinsky. "Unlike many other additive manufacturing processes that rely on polymer-based binders, XJet uses a water-based system, which we believe leads to better material properties and higher biocompatibility after sintering. The NPJ platform also allows for exceptionally high resolution and surface detail, which is critical for replicating the complex anatomical contours of vertebral endplates, including complex lattice structures for bone integration and polymer bonding to the material. This accuracy contributes significantly to a better fit and performance of the implants."
The implants were subjected to several tests conducted at the University of South Florida (USF) and the University of Connecticut Institute of Materials Science (UConn IMS). At USF, EvoFlex implants were tested on the Dynamic Investigation of Spine Characteristics (DISC) simulator with six degrees of freedom under physiologic load on the spine. These tests resulted in stiffness curves and motion profiles that closely resemble the natural behavior of the human spine. The compression and shear tests conducted at UConn IMS showed significant improvements in structural performance. The new design allows compressive loads of 14.6 kN, equivalent to a force of approximately 3,300 pounds. The UConn IMS also conducted simulated body fluid (SBF) testing and SEM-EDX analysis, which confirmed that the ZTA ceramic not only supports uniform mineral deposition and biologically relevant ion interaction, but also exhibits bone-like surface behavior and long-term osseointegration potential. In contrast to metals, the ceramic showed a consistent, controlled and predictable biological response.
The endplates for my own spine are now ready. This is the difference between a life with chronic pain and a return to normality and physical activity..
Todd Hodrinsky
The prototype demonstrates the successful transition from research to scalable clinical manufacturing. With two U.S. patents already issued and six patents pending, Nivalon is preparing for NIH Phase II SBIR funding, clinical trials for FDA PMA approval and first-in-patient use planned for 2026. "This is more than a technical achievement—it's something very personal," said Hodrinsky and Janse. "The endplates for my own spine are now ready. It's the difference between living with chronic pain and returning to normality and physical activity."
Date: 08.12.2025
Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.
Consent to the use of data for promotional purposes
I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planck-Str. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here
Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.
Additionally, my consent also includes the processing of my email address and telephone number for data matching for marketing purposes with select advertising partners such as LinkedIn, Google, and Meta. For this, Vogel Communications Group may transmit said data in hashed form to the advertising partners who then use said data to determine whether I am also a member of the mentioned advertising partner portals. Vogel Communications Group uses this feature for the purposes of re-targeting (up-selling, cross-selling, and customer loyalty), generating so-called look-alike audiences for acquisition of new customers, and as basis for exclusion for on-going advertising campaigns. Further information can be found in section “data matching for marketing purposes”.
In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here. This does not apply to data matching for marketing purposes.
Right of revocation
I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://contact.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.